Skip to Menu Skip to Search Contact Us Skip to Content

Patient monitoring studies for cellular and gene therapy from SGS – gain the vital data you need to advance drug development for new treatments.

Bioanalytical

Cellular and gene therapy technology has become an important strategy for developing crucial new treatments. We offer you essential patient monitoring studies for cellular and gene therapy to establish any long-term persistency of the viral vector, or reactivation of the vector.

Why choose patient monitoring studies for cellular and gene therapy from SGS?

We can help you:

  • Monitor clinical material from patients exposed to gene therapy transfer medicinal products with accurate data from our quantitative real time polymerase chain reaction (qPCR) assays
  • Address regulatory concerns and provide an important part of the safety evaluation of gene therapy technologies through our analysis of biodistribution studies

Trusted patient monitoring studies for cellular and gene therapy from a leading provider

As the world-leader in inspection, verification, testing and certification, we provide unrivaled experience in patient monitoring studies for cellular and gene therapy. Plus, we offer the latest technical and regulatory expertize, combined with our unique global network, to provide you with the accurate data you need to develop new drug products.

To find out more about our patient monitoring studies for cellular and gene therapy, contact us today.